Yoshida Masahiro, Ma Jun, Tomita Tsutomu, Morikawa Norihiro, Tanaka Nobuyoshi, Masamura Katsuhiko, Kawai Yasuyuki, Miyamori Isamu
Third Department of Internal Medicine, Faculty of Medicine, Fukui, Shimoaituski 23, Yoshida-gun, Matsuoka-cho, Fukui 910-1193 Japan.
Congest Heart Fail. 2005 Jan-Feb;11(1):12-6. doi: 10.1111/j.1527-5299.2005.03722.x.
Mineralocorticoid receptors (MRs) have been identified in the human cardiovascular tissues. We determined MR expression in the failing heart to clarify the mechanism of action of aldosterone antagonist in the treatment of congestive heart failure. MR protein and MR mRNA content were detected by immunohistochemical staining and in situ hybridization in the cardiac tissues. Immunohistochemical staining of the receptor, as well as in situ hybridization of MR mRNA, was dense in cardiomyocytes of the failing left ventricle as compared with the controls. The staining ratio of the cytoplasm to the interstitium showed that MRs were located mainly in the cytoplasm. The cytoplasm to the interstitium in the failing left ventricle was 1.53+/-0.13, which was significantly higher than that of the controls 1.25+/-0.19 (p<0.05). These findings suggest that the efficacy of aldosterone antagonists in treating congestive heart failure may be in part through blocking the MRs, which are upregulated in the failing heart.
盐皮质激素受体(MRs)已在人体心血管组织中被鉴定出来。我们测定了衰竭心脏中MR的表达,以阐明醛固酮拮抗剂治疗充血性心力衰竭的作用机制。通过免疫组织化学染色和原位杂交检测心脏组织中的MR蛋白和MR mRNA含量。与对照组相比,衰竭左心室心肌细胞中受体的免疫组织化学染色以及MR mRNA的原位杂交均呈高密度。细胞质与间质的染色比例显示,MRs主要位于细胞质中。衰竭左心室的细胞质与间质比例为1.53±0.13,显著高于对照组的1.25±0.19(p<0.05)。这些发现表明,醛固酮拮抗剂治疗充血性心力衰竭的疗效可能部分是通过阻断在衰竭心脏中上调的MRs来实现的。